Skip to content
LEADERSHIP MANAGEMENTPackaged Foods

Manorama Industries Limited announces a leadership change

Manorama Industries LimitedMANORAMA

TL;DR

The transition was structured to take effect immediately on 12 November 2026: Ashish Ramesh Saraf resigned as Chairman and Managing Director effective 12 November 2026 and consented to move to President – Strategic Planning and Business Development, subject to Board approval. Vinita Ashish Saraf resigned as Vice-Chairperson and Whole-Time Director effective 12 November 2026 and consented to become President – Business Excellence and Development, also subject to Board approval.

Per the resignation disclosures filed with the exchanges, what is the specific timeline for the transition of executive responsibilities, and has the Board appointed an interim MD or CEO to ensure continuity of operations?

The transition was structured to take effect immediately on 12 November 2026:

  • Ashish Ramesh Saraf resigned as Chairman and Managing Director effective 12 November 2026 and consented to move to President – Strategic Planning and Business Development, subject to Board approval. [1]
  • Vinita Ashish Saraf resigned as Vice-Chairperson and Whole-Time Director effective 12 November 2026 and consented to become President – Business Excellence and Development, also subject to Board approval. [2]
  • The Board subsequently approved both redesignations with effect from 12 November 2026. [3]

For continuity, the Board approved Deep Saraf as an executive/whole-time director for a five-year term from 12 November 2026 to 11 November 2031, subject to shareholder approval. [3] A contemporaneous report describes this appointment as Managing Director, also subject to shareholder approval. [4]

Conclusion: there was no separately identified interim MD or CEO appointment in the resignation letters themselves. Continuity was addressed through the same-day transfer of the outgoing executives into President roles and the appointment of Deep Saraf as the incoming executive leader, subject to member approval.

Given the resignation of the Chairman & MD and Vice-Chairperson, what specific disclosures have been made regarding the continuity of the company’s long-term strategic growth initiatives, particularly the capacity expansion projects outlined in the most recent Annual Report?

The disclosures point to continuity of strategic execution, not a change in the long-term growth agenda. However, there is no project-specific reaffirmation in the resignation materials that the capacity-expansion projects described in the latest Annual Report will proceed on their original timetable or budget.

What was specifically disclosed

  • Strategic roles retained: Ashish Ramesh Saraf resigned as Chairman and Managing Director effective November 12, 2026, but consented to become President – Strategic Planning and Business Development, subject to Board approval [1].
  • Business-execution role retained: Vinita Ashish Saraf resigned as Vice-Chairperson and Whole-Time Director effective the same date, but consented to become President – Business Excellence and Development, also subject to Board approval [2].
  • Continuity was an explicit rationale: The Board approved the redesignation of both executives “in the interest of continuity of management” [3].
  • Successor executive structure: The Board also approved Deep Saraf’s appointment as an Executive Director and Whole-Time Director for a five-year term, subject to shareholder approval [3].

What this means for the capacity-expansion programme

The disclosed structure preserves the outgoing leadership’s involvement in strategic planning and business development rather than removing it entirely. That is supportive of strategic continuity at the leadership level, particularly because the former Chairman & MD is moving into a role explicitly responsible for strategic planning.

But the disclosure stops short of confirming:

  • that each capacity-expansion project in the latest Annual Report remains approved;
  • unchanged project scope, capital outlay or commissioning schedule;
  • funding arrangements or incremental debt requirements;
  • construction or commissioning milestones; or
  • expected capacity and revenue contribution from those projects.

Accordingly, the evidence supports continuity of management oversight, but not yet continuity of individual expansion-project execution on unchanged terms. The cited resignation and Board-outcome disclosures do not provide a project-by-project update on the Annual Report’s capacity-expansion plans.

Have there been any corresponding filings regarding changes to the promoter group’s shareholding pattern or the appointment of new directors to maintain the required board composition and committee structures under SEBI LODR regulations following these departures?

Yes for board appointments, but a post-departure promoter-shareholding filing or committee-reconstitution filing is not confirmed.

  • Departures: Ashish Ramesh Saraf resigned as Chairman and Managing Director, and Vinita Ashish Saraf resigned as Vice-Chairperson and Whole-Time Director, both effective 12 November 2026. Their letters state that they would move into strategic-management roles subject to Board approval. [2] [1]
  • New directors and leadership: The Board reportedly approved Deep Saraf as an Additional Director in the Executive Director/Whole-Time Director category for a five-year term, subject to shareholder approval. [3] A separate report states that Mudit Kumar Singh was appointed Chairman and Executive Director, also subject to shareholder approval. [5]
  • Independent-director process: Before these departures, the company had initiated a postal ballot seeking shareholder approval for Dr. Rohini Tiwari’s appointment as a non-executive Independent Director. [6]
  • Promoter shareholding: The latest validated shareholding record is Q2 FY27, before the 12 November departures. Promoter ownership fell to 51.38% from 54.32% in Q1 FY27, while promoter encumbrance remained 0.00% of promoter holdings. Ashish Ramesh Saraf held 43.68% and Vinita Ashish Saraf 7.24%. This reflects a pre-departure shareholding change, not a confirmed filing after their executive resignations.
  • Committee structures: The cited material does not confirm a post-departure reconstitution of the Audit Committee, Nomination and Remuneration Committee, Stakeholders’ Relationship Committee, or other committee memberships. It therefore cannot yet establish that the revised board and committee structure fully satisfies the applicable SEBI LODR requirements.

Analyst read: The immediate governance response appears to be the induction or elevation of directors, particularly Deep Saraf and Mudit Kumar Singh, with shareholder approvals still relevant. The key unresolved item is a formal exchange filing showing the final board composition, independent-director balance, committee memberships, and whether Ashish and Vinita Saraf continue to be classified within the promoter group after their redesignation into senior-management roles.

Sources

  1. [1]Resignation of Chairman & MD and Vice-Chairperson & Whole-Time Director of Manorama Industries Limited — 2026-11-12T20:53:42, p.1
  2. [2]Resignation of Chairman & MD and Vice-Chairperson & Whole-Time Director of Manorama Industries Limited — 2026-11-12T20:53:42, p.2
  3. [3]Manorama Industries board approves unaudited results and key leadership changes | InvestyWise — Investywise, 2026-11-12T00:00:00
  4. [4]Manorama Industries Board Meeting and Q2 FY27 Results – Perivis — Blog, 2026-11-13T04:04:34.045846
  5. [5]Manorama Industries Limited — Appointment | Manorama Industries (MANORAMA) — Docstox, 2026-11-12T00:00:00
  6. [6]Manorama Industries completes postal ballot dispatch for independent director appointment — Scanx, 2026-09-19T00:00:00

Keep digging

Per the resignation disclosures filed with the exchanges, what is the specific timeline for the transition of executive responsibilities, and has the Board appointed an interim MD or CEO to ensure continuity of operations?

Ask Copilot
Logo

Unlock financial AI for your firm